BIO 2026: Cell and gene therapy firms outline their use of AI in manufacturing
From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.
24 June 2026
24 June 2026
From data lakes to streamlined production, Kriya, Opus, and Epicrispr discuss how technology is improving their operations.
With a regulatory route now in place, Regenxbio expects to meet with the FDA again in July, with a BLA resubmission to follow in Q3 2026.
The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop.
This partnership marks another addition to the growing list of high-profile collaborations between the consumer health and life science sectors.
Haisco will receive $40m upfront and may earn up to $1.4bn in additional milestone payments.
Combotope will deploy its platform to discover antibodies, accompanied by a specific antibody characterisation data package.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.